These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38057786)

  • 41. Novel Adipokines CTRP1, CTRP9, and FGF21 in Pediatric Type 1 and Type 2 Diabetes: A Cross-Sectional Analysis.
    Arking A; Sarver DC; Magge SN; Wong GW; Wolf RM
    Horm Res Paediatr; 2022; 95(1):43-50. PubMed ID: 35172300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review.
    Yuan D; Wu BJ; Henry A; Rye KA; Ong KL
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):47-55. PubMed ID: 30346647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Buizen L; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Rye KA; Keech AC;
    Diabetologia; 2015 Sep; 58(9):2035-44. PubMed ID: 26055067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary artery calcification, carotid intima-media thickness and cardiac dysfunction in young adults with type 2 diabetes mellitus.
    Joseph TP; Kotecha NS; Kumar H B C; Jain N; Kapoor A; Kumar S; Bhatia E; Mishra P; Sahoo SK
    J Diabetes Complications; 2020 Aug; 34(8):107609. PubMed ID: 32402843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria.
    Xu L; Niu M; Yu W; Xia W; Gong F; Wang O
    J Diabetes Complications; 2017 Mar; 31(3):583-588. PubMed ID: 27916484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
    Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
    J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Scott RS; Taskinen MR; Keech AC; Rye KA
    Diabetologia; 2015 Mar; 58(3):464-73. PubMed ID: 25425220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Serum Uric Acid Level and Carotid Atherosclerosis and Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.
    Li W; Wang Y; Ouyang S; Li M; Liu R; Zhang Y; Liu X; Li T; Liu S
    Front Endocrinol (Lausanne); 2022; 13():890305. PubMed ID: 35769075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-normal serum unconjugated bilirubin levels are associated with late but not early carotid atherosclerotic lesions in T2DM subjects.
    Jin CH; Wang JW; Ke JF; Li JB; Li MF; Li LX
    Front Endocrinol (Lausanne); 2022; 13():948338. PubMed ID: 36407305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus.
    Guo C; Zhao L; Li Y; Deng X; Yuan G
    J Cell Physiol; 2021 Jan; 236(1):55-67. PubMed ID: 32583417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of fibroblast growth factor 21 with metabolic syndrome and endothelial function in children: a prospective cross-sectional study on novel biomarkers.
    Domouzoglou EM; Vlahos AP; Cholevas VK; Papafaklis MI; Chaliasos N; Siomou E; Michalis LK; Tsatsoulis A; Naka KK
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):242-251. PubMed ID: 34015901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications.
    Tantawy N; Sherif E; Matter RM; Salah N; Abozeid NE; Atif H
    Pediatr Endocrinol Diabetes Metab; 2023; 29(2):64-74. PubMed ID: 37728457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes.
    Yafei S; Elsewy F; Youssef E; Ayman M; Elshafei M; Abayazeed R
    Diab Vasc Dis Res; 2019 Jul; 16(4):378-384. PubMed ID: 31271311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between physical activity and circulating fibroblast growth factor 21 in middle-aged and older adults.
    Matsui M; Kosaki K; Tanahashi K; Akazawa N; Osuka Y; Tanaka K; Kuro-O M; Maeda S
    Exp Gerontol; 2020 Nov; 141():111081. PubMed ID: 32911033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes.
    Catalan M; Herreras Z; Pinyol M; Sala-Vila A; Amor AJ; de Groot E; Gilabert R; Ros E; Ortega E
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):742-8. PubMed ID: 26033395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma.
    Li X; Yu H; Yin J; Li L; Zhou J; Li M; Li Q; Chen H; Liu F; Bao Y; Han J; Jia W
    Sci Rep; 2017 Feb; 7():43123. PubMed ID: 28225059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.